[PGI2 therapy in congestive heart failure and its effects on the sympathetic nervous activity].
D000368:Aged; D011464:Epoprostenol / Q000627:therapeutic use*; D005260:Female; D006333:Heart Failure / Q000188:drug therapy* / Q000503:physiopathology; D006439:Hemodynamics; D006801:Humans; D008297:Male; D008875:Middle Aged; D011453:Prostaglandins / Q000627:therapeutic use*; D013564:Sympathetic Nervous System / Q000503:physiopathology*
D011453:Prostaglandins; D011464:Epoprostenol